The state wasn’t going to allow outdoor farming until… people successfully convinced the regulators to allow sun-grown weed. It’s also the more environmentally friendly choice. Outdoor farming will always use less energy. Indoor farmers need a lot of power to run their lights and fans. Just like the grape vines for winemaking, pot plants absorb…
In this new study, a large group of Brazilian scientists carried out the first randomized placebo-controlled trial with ayahuasca, treating 29 patients with treatment-resistant depression. Half of the patients were treated with ayahuasca, and the other half with placebo. “We observed a significant placebo effect, but the effects of ayahuasca were superior, and lasted longer,”…
Its scientific advisory board includes Tom Insel, the former director of the National Institutes of Mental Health.While most of the research is being led by universities and non-profit research institutions, Compass, a for-profit company founded in 2016, sees itself as helping to fill in the gaps … For the trial, which is set to begin within…
About 500 brain experts from 29 countries are attending the group’s annual meeting, CNS 2018 (27th Annual Computational Neuroscience Meeting), which has been jointly organized by the Allen Institute for Brain Science and the University of Washington. [An] experiment took advantage of functional MRI brain scans to document how psilocybin changed brain activity. The psychedelic drug reduced the activity of…
Greg Boyce, a member of Kasson’s team, looked at all the chemicals found in the white fungal plugs of the various cicadas. And to his shock, he found that the banger-wings were loaded with psilocybin—the potent hallucinogen found in magic mushrooms. “At first, I thought: There’s absolutely no way,” he says. “It seemed impossible.” After…
Small doses of a THC compound found in marijuana have made old mice suddenly come alive with a “young brain, according to a study by a team of Bonn University researchers and colleagues from The Hebrew University in Jerusalem, published in the journal Nature Medicine. When asked how they had tested a mouse’s memory, Professor…
“It’s a watershed event to get FDA approval,” says Sasha Kaplun, vice president for corporate development at Auxly Cannabis Group Inc., an investment partnership in Toronto. Approval should help alleviate skepticism among some physicians about the plant’s medical uses, Kaplun says. At the company’s headquarters in London’s Mayfair district, a preferred locale for hedge funds, the…
*British Museum Queen Elizabeth II Great Court “[Psychedelics] have a revolutionary potential, and that’s not an exaggeration,” says Dr Robin Carhart-Harris, who will lead the study. Now UK researchers are about to take part in the first major trials into whether one of these hallucinogenic drugs could be more effective than a leading antidepressant…
The paper, published May 7, 2018 in the Journal of Psychopharmacology, shows evidence that harmful long-term effects of MDMA are probably caused by very high doses that most people don’t actually take. -Study’s authors were led by Balázs Szigeti, a Ph.D. candidate at the University of Edinburgh, In the Global Drug Survey, which includes recreational ecstasy use data…
The study, led by UC Davis chemist David E. Olson, was published Tuesday, June 12th, in the journal Cell Reports. The discovery of this neurite-promoting property could shed light on why these chemically distinct drugs all appear helpful in treating depression, anxiety, addiction and post-traumatic stress disorder, or PTSD, Olson said. In test tubes as well as…
Recent Comments